🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis

RecruitingPhase 1, Phase 2Ages 18 Years - 70 YearsAllBond Biosciences
NCT07371793 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study will be conducted in two parts run in parallel. Part 1 of the study (Phase 1, randomized, double-blind, placebo-controlled, multiple ascending dose) will enroll healthy volunteers in 3 sequential dose escalating cohorts with BBI-101 or placebo administered 3 times per day (TID) for 14 days. Part 2 of the study (Phase 2a, randomized, multiple dose, two-period, two-sequence crossover) will evaluate the effect of BBI-001 on blood iron parameters in patients with hereditary hemochromatosis receiving 8 doses of BBI-001 or placebo treatment administered TID in Period 1 followed by administration of reverse treatment in Period 2. Dosing periods will be separated by 12 days.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Healthy volunteers (Part 1) or patients with hereditary hemochromatosis (Part 2) Exclusion Criteria: Serious or unstable medical or psychiatric conditions Significant medical history Current infections Alcohol use disorder Receiving iron chelation therapy or treatment other than stable maintenance phlebotomy for the prior 6 months (Part 2) Organ damage from iron overload in the view of the principal investigator would prevent successful completion of the protocol (Part 2)
💊

What it tests

  • BBI-001
  • Placebo
📍

Where

1 site
Clinical Research Unit
Sydney, Australia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy